Vered Bisker-Leib
Equibles does not estimate personal net worth.
Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CMPX alertsAbout Vered Bisker-Leib
Vered Bisker-Leib is recorded as COO at Compass Therapeutics, Inc. (CMPX) since June 17, 2020. The newest filing on record that lists Vered Bisker-Leib as COO at Compass Therapeutics, Inc. (CMPX) is dated April 27, 2023. Compass Therapeutics, Inc. reported in an 8-K filed May 28, 2024 that Vered Bisker-Leib resigned as member of the Board of Directors, effective May 28, 2024. Compass Therapeutics, Inc. reported in an 8-K filed May 28, 2024 that Vered Bisker-Leib resigned as Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer), effective May 28, 2024. The proxy statement of Compass Therapeutics, Inc. reports total compensation of $6,433,665 for Vered Bisker-Leib in fiscal 2024, including a base salary of $600,000. Disclosed compensation is on record for 6 fiscal years. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman) and 7 others.
“On May 28, 2024, Vered Bisker-Leib, PhD, MBA, resigned as Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) and resigned as a member of the Board of Directors, of Compass Therapeutics, Inc. (the “Company”) effective the same date.”
“On May 28, 2024, Vered Bisker-Leib, PhD, MBA, resigned as Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) and resigned as a member of the Board of Directors, of Compass Therapeutics, Inc. (the “Company”) effective the same date.”
Affiliation history
-
Current
2020-06-17–present
Last confirmed April 27, 2023
-
2017-01-01–2024-05-28
Company network
Leadership on record at Compass Therapeutics, Inc.
- Thomas J. Schuetz CEO, Board Member
- Thomas Schuetz CEO, Board Member
- Thomas Schuetz, MD, PhD CEO, Chairman
- Vered Bisker-Leib, PhD CEO, Board Member
- Barry Shin CFO
- Dr. Bisker-Leib COO
- Jonathan E. Anderman General Counsel
- Neil Lerner Chief Accounting Officer
- Brett Kaplan, M.D. Board Member
- David Wurzer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Compass Therapeutics, Inc. (CMPX) | Ph.D., MBA Formerly Chief Executive Officer | $600,000 | $6,433,665 |
| 2023 | Compass Therapeutics, Inc. (CMPX) | Ph.D., MBA Formerly Chief Executive Officer | $500,000 | $4,067,284 |
| 2022 | Compass Therapeutics, Inc. (CMPX) | Ph.D., MBA Chief Executive Officer (formerly President and COO) | $475,000 | $1,724,739 |
| 2021 | Compass Therapeutics, Inc. (CMPX) | Ph.D., MBA President and Chief Operating Officer | $400,000 | $4,450,000 |
| 2020 | Compass Therapeutics, Inc. (CMPX) | Ph.D., MBA President and Chief Operating Officer | $360,000 | $2,571,579 |
| 2019 | Compass Therapeutics, Inc. (CMPX) | Ph.D., MBA President and Chief Operating Officer | $325,000 | $1,055,034 |